APA (7th ed.) Citation

Li, Q., Zhou, Z., Lu, J., Luo, H., Wang, S., Peng, Y., . . . Xu, C. (2022). PD-L1P146R is prognostic and a negative predictor of response to immunotherapy in gastric cancer. Molecular therapy, 30(2), 621-631. https://doi.org/10.1016/j.ymthe.2021.09.013

Chicago Style (17th ed.) Citation

Li, Qing, et al. "PD-L1P146R Is Prognostic and a Negative Predictor of Response to Immunotherapy in Gastric Cancer." Molecular Therapy 30, no. 2 (2022): 621-631. https://doi.org/10.1016/j.ymthe.2021.09.013.

MLA (9th ed.) Citation

Li, Qing, et al. "PD-L1P146R Is Prognostic and a Negative Predictor of Response to Immunotherapy in Gastric Cancer." Molecular Therapy, vol. 30, no. 2, 2022, pp. 621-631, https://doi.org/10.1016/j.ymthe.2021.09.013.